Frequency and cost of serious adverse drug reactions in a department of general medicine.
about
Applications of CYP450 testing in the clinical settingComorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort studyRisk factors for adverse events in analgesic drug users: results from the PAIN studyAdverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodesReal time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyDoing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in NigeriaDifferences between Drug-Induced and Contrast Media-Induced Adverse Reactions Based on Spontaneously Reported Adverse Drug ReactionsAdverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and ReportingComparative evaluation of methods approximating drug prescription durations in claims data: modeling, simulation, and application to real data.Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.Pharmacovigilance for psychiatrists: An introductionHow to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.The contribution of a clinical pharmacist to the improvement of medication at a geriatric hospital unit in NorwaySex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands.Adverse drug reactions in hospital in-patients: a pilot study.A study on drug safety monitoring program in India.A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care settingSeriousness, preventability, and burden impact of reported adverse drug reactions in Lombardy emergency departments: a retrospective 2-year characterization.Critical gaps in the world's largest electronic medical record: Ad Hoc nursing narratives and invisible adverse drug events.Adverse drug reactions: current issues and strategies for prevention and management.Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda.The cost of adverse drug reactions.Pharmacovigilance: scope for a dermatologistAdverse drug reactions in elderly patientsAdverse drug reactions in a complementary medicine hospital: a prospective, intensified surveillance study.Pharmacoeconomics of adverse drug reactions.Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care HospitalPattern of Angiotensin-converting enzyme inhibitors induced adverse drug reactions in South Indian teaching hospitalRepeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules.Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicineNumber of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review.Imputation of adverse drug reactions: Causality assessment in hospitalsStarting a pharmacovigilance program within a teaching hospital: Challenges and experiences from Lalitpur, Nepal.EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit.Pravastatin-induced lichenoid drug eruption.Antidepressant-drug interactions are potentially but rarely clinically significant.Adverse drug reactions to antiretroviral therapy: prospective study in children in sikasso (mali).Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study.
P2860
Q24621760-7C161D0B-0DAA-4847-93CF-FADDE9AB3F07Q24652604-60EE7163-0275-4EA7-8EC6-87FC1EB54201Q28165652-1FE14C83-C410-4567-81A6-7F73E5674175Q28474740-45B80881-7C63-4054-8BC9-B3985EAF2C17Q28482250-5A2087A7-522E-4428-ABD5-063BACD2B5BCQ28544462-CD967F58-DAC7-4F05-9770-C45685B2BE04Q28550754-CADB0872-AC90-4159-95C7-4B87623982F8Q28554059-3DD6387C-6F62-4178-B72B-19600C338EA8Q31131015-C2ADF073-C2FC-4CAB-B376-4B69876B5FE3Q31145263-F4D1A9A8-ADD2-4AB2-B27D-9AC165DEDD43Q33692129-829F3B90-796A-4D72-B68B-6904DD78B88FQ34093093-C9F3A88F-9AC6-4170-AF42-A6C663C5C3A9Q34100728-7BFC238A-5CB1-4E1B-B62A-09858B62FD79Q34476110-4CE23A39-F6A7-4B27-84C0-519ABE4338FAQ34553227-373EABC3-E307-45E9-B006-4724542F89F9Q34568354-96321FB2-7300-4F26-A84A-A25CF2EB2584Q34637462-3AF29ED9-A0AE-4FF0-9669-1FC23423E727Q34657198-8A62A38D-9514-457E-B125-B9D507856379Q34685924-66C5725F-144E-4C37-9598-39444F419BB1Q34789132-28142151-3D46-4A70-AC67-8831DC94E967Q34791068-49798EFF-8318-4207-B126-9381B13AD245Q34973250-57F4C02E-786D-4B62-A976-4DFEA9B33010Q35076575-2FBA835A-B01D-4520-9111-A63E65729315Q35564598-633836AA-70DA-4851-B2BD-24D9FCA117EBQ35641447-78EED7C7-5943-4B4E-B0AB-43E927ED0B8FQ35726187-EDE0AC40-74BA-440A-A3A1-D1DA2E2F40F0Q35775295-72C26B1C-3823-47F7-89BA-CD35E4012766Q35884512-5A735B3A-B0E9-41BB-8786-DB3C6FE7F88FQ35906518-24680736-C5CF-469F-B82B-BAA2B5CF6FAFQ36024348-036991E1-3ADA-43AC-90AC-942733459FA8Q36040772-4CB2F7FC-1954-44FC-ADDC-058F4F829427Q36055056-EF55586B-06C2-424F-8D4F-61F9E1482F79Q36125519-B840C488-3134-46C4-B14E-740AC1007279Q36271730-471CDA35-6C73-4F29-B144-BE14655BE457Q36316958-64E7E67B-614F-41A5-9FBD-6F961C3CBEEDQ36343488-1962DECE-3E6C-4887-B4C6-59160AFB3D9EQ36365413-17685A4E-ACCE-44E9-A73A-6849232BA62EQ36538987-63FF18AD-442F-4719-858B-D0AB6934FEBDQ36596948-6BD16CE6-636E-4E0F-9F36-DA7861BFDDC4Q37021509-497C76C0-9816-496F-ACBD-FA63F4525BA7
P2860
Frequency and cost of serious adverse drug reactions in a department of general medicine.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@ast
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@en
type
label
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@ast
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@en
prefLabel
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@ast
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@en
P2093
P2860
P1476
Frequency and cost of serious adverse drug reactions in a department of general medicine.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2125.1998.00667.X
P407
P577
1998-03-01T00:00:00Z